Dispenzieri A - Search Results

1

Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications.

Fermand JP, Bridoux F, Dispenzieri A, Jaccard A, Kyle RA, Leung N, Merlini G. Fermand JP, et al. Among authors: dispenzieri a. Blood. 2018 Oct 4;132(14):1478-1485. doi: 10.1182/blood-2018-04-839480. Epub 2018 Jul 16. Blood. 2018. PMID: 30012636 Free article. Review.

2

Clinical significance of the translocation (11;14)(q13;q32) in multiple myeloma.

Fonseca R, Hoyer JD, Aguayo P, Jalal SM, Ahmann GJ, Rajkumar SV, Witzig TE, Lacy MQ, Dispenzieri A, Gertz MA, Kyle RA, Greipp PR. Fonseca R, et al. Among authors: dispenzieri a. Leuk Lymphoma. 1999 Nov;35(5-6):599-605. doi: 10.1080/10428199909169625. Leuk Lymphoma. 1999. PMID: 10609798

3

Prognostic value of bone marrow angiogenesis in multiple myeloma.

Rajkumar SV, Leong T, Roche PC, Fonseca R, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, Kyle RA, Gertz MA, Greipp PR. Rajkumar SV, et al. Among authors: dispenzieri a. Clin Cancer Res. 2000 Aug;6(8):3111-6. Clin Cancer Res. 2000. PMID: 10955791

4

Thalidomide in the treatment of relapsed multiple myeloma.

Rajkumar SV, Fonseca R, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, Kyle RA, Gertz MA, Greipp PR. Rajkumar SV, et al. Among authors: dispenzieri a. Mayo Clin Proc. 2000 Sep;75(9):897-901. doi: 10.4065/75.9.897. Mayo Clin Proc. 2000. PMID: 10994824

5

Effect of complete response on outcome following autologous stem cell transplantation for myeloma.

Rajkumar SV, Fonseca R, Dispenzieri A, Lacy MQ, Witzig TE, Lust JA, Larson D, Therneau TM, Kyle RA, Litzow MR, Greipp PR, Gertz MA. Rajkumar SV, et al. Among authors: dispenzieri a. Bone Marrow Transplant. 2000 Nov;26(9):979-83. doi: 10.1038/sj.bmt.1702640. Bone Marrow Transplant. 2000. PMID: 11100277

6

Retrospective cohort study of 148 patients with polyclonal gammopathy.

Dispenzieri A, Gertz MA, Therneau TM, Kyle RA. Dispenzieri A, et al. Mayo Clin Proc. 2001 May;76(5):476-87. doi: 10.4065/76.5.476. Mayo Clin Proc. 2001. PMID: 11357794 Review.

7

Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival.

Dispenzieri A, Lacy MQ, Kyle RA, Therneau TM, Larson DR, Rajkumar SV, Fonseca R, Greipp PR, Witzig TE, Lust JA, Gertz MA. Dispenzieri A, et al. J Clin Oncol. 2001 Jul 15;19(14):3350-6. doi: 10.1200/JCO.2001.19.14.3350. J Clin Oncol. 2001. PMID: 11454882

8

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma.

Porrata LF, Gertz MA, Inwards DJ, Litzow MR, Lacy MQ, Tefferi A, Gastineau DA, Dispenzieri A, Ansell SM, Micallef IN, Geyer SM, Markovic SN. Porrata LF, et al. Among authors: dispenzieri a. Blood. 2001 Aug 1;98(3):579-85. doi: 10.1182/blood.v98.3.579. Blood. 2001. PMID: 11468153 Free article.

9

Thalidomide for previously untreated indolent or smoldering multiple myeloma.

Rajkumar SV, Dispenzieri A, Fonseca R, Lacy MQ, Geyer S, Lust JA, Kyle RA, Greipp PR, Gertz MA, Witzig TE. Rajkumar SV, et al. Among authors: dispenzieri a. Leukemia. 2001 Aug;15(8):1274-6. doi: 10.1038/sj.leu.2402183. Leukemia. 2001. PMID: 11480571 Clinical Trial.

10

Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosis.

Hayman SR, Bailey RJ, Jalal SM, Ahmann GJ, Dispenzieri A, Gertz MA, Greipp PR, Kyle RA, Lacy MQ, Rajkumar SV, Witzig TE, Lust JA, Fonseca R. Hayman SR, et al. Among authors: dispenzieri a. Blood. 2001 Oct 1;98(7):2266-8. doi: 10.1182/blood.v98.7.2266. Blood. 2001. PMID: 11568015 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

979 results

Search Page

Filters